My watch list
my.bionity.com  
Login  

A novel BCMA|[sol]|CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

Leukemia advance online publication, January 13 2017. doi:10.1038/leu.2016.388

Authors: S Hipp, Y-T Tai, D Blanset, P Deegen, J Wahl, O Thomas, B Rattel, P J Adam, K C Anderson & M Friedrich

Authors:   S Hipp; Y-T Tai; D Blanset; P Deegen; J Wahl; O Thomas; B Rattel; P J Adam; K C Anderson; M Friedrich
Journal:   Leukemia
Volume:   aop
edition:   current
Year:   2017
DOI:   10.1038/leu.2016.388
Publication date:   27-Dec-2017
Facts, background information, dossiers
More about Nature Publishing Group
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE